Vitamin D halves the rate of asthma attacks that lead to hospitalization

Image

Journal of Clinical Immunology and Allergy is a world class open access journal intended to publish the cutting-edge research in the field of Immunology and Allergy.

Journal of Clinical Immunology and Allergy has developed very significantly as a speciality over the past years, and has the understanding of the immunological basis of many diseases and the development of immunological therapies.

Asthma is a condition in which your airways narrow and swell and produce extra mucus. This can make breathing difficult and trigger coughing, wheezing and shortness of breath. Asthma can't be cured, but its symptoms can be controlled. Because asthma often changes over time.

Asthma affects more than 300 million people worldwide and is estimated to cause almost 400 000 deaths annually, Asthma mortality arises primarily during episodes of acute worsening of symptoms, termed exacerbations, which are commonly precipitated by viral upper respiratory infections.

Symptoms:

Asthma symptoms vary from person to person. You may have infrequent asthma attacks, have symptoms only at certain times — such as:

Shortness of breath

• Chest tightness or pain

• Trouble sleeping caused by shortness of breath, coughing or wheezing

• A whistling or wheezing sound when exhaling.

vitamin D supplements along with standard systemic corticosteroids halves the rate of severe asthma attacks that lead to either hospitalization or a visit to the emergency department, and reduces the rate of asthma attacks requiring steroid treatment by nearly one third, according to findings from a recent meta-analysis.

The study also found that vitamin D supplementation greatly reduced severe asthma attacks in patients with insufficient vitamin D levels. “These results add to the ever-growing body of evidence that vitamin D can support immune function as well as bone health.

vitamin D supplementation did not significantly reduce the rate of severe asthma attacks in patients with higher baseline status. Due to relatively small numbers of patients within subgroups of patients, the researchers could show no definitive evidence that the effects of vitamin D differed across subgroups.

Subgroup analysis didn't provide consensus on dosing vitamin D supplements either, although the doses given to patients were found to be safe with no instances of elevated blood calcium levels or kidney stones. Serious adverse events were comparable between vitamin D and placebo groups.

A new era in treating allergy has emerged in recent years and its noticeable success has been characterized as "the end of the beginning."

An approach similar to that used in severe eosinophilic asthma with frequent exacerbations can certainly be adapted to the CF population where by the common important denominator is inflammation. Allergic diseases include hay fever, food allergies, atopic dermatitis, allergic asthma, and anaphylaxis. An allergy is an unnecessary immune response to an innocuous substance. The most common way to diagnose an IgE-mediated allergy is through a blood test to identify allergen specific IgE or a skin prick test which results in a local inflammatory reaction after administration of the trigger allergen.

To provide with the more detailed information the journal accepts original manuscripts in the form of Research Articles, Review Articles, Clinical Reviews, Commentaries, Case Reports, Perspectives and Short Communications encompassing all aspects of Clinical Immunology and Allergy for publication in open access platform.

All the manuscript published by Clinical Immunology and Allergy are available freely online immediately after publication without any subscription charges or registration.

Manuscripts can be submitted at:http://www.imedpub.com/submissions/insights-allergy-asthma-bronchitis.html or can be submitted as an attachment to this

E-mail: clinicalimmuno@clinicalmedicaljournals.com

Open Access: Permanent free access to your article upon publication ensures extensive global reach and readership.

Global Marketing: Through promotion in a targeted global email announcement or press release, your article will be seen by thousands of the top-most thought-leaders in your field.

Social Media Exposure: Extended reach for your article through links on Twitter accounts provides maximum visibility worldwide.

Media Contact
Sana George
Journal Manager
Clinical Immunology and Allergy
Email: clinicalimmuno@clinicalmedicaljournals.com
WhatsApp: +1-947-333-4405